NCT06522074View on ClinicalTrials.gov

Evaluating the Role of IGF-1 and S-Klotho In Plaque Phenotype and Vulnerability: the VISION Study.

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Ischemic Heart DiseaseChronic Coronary SyndromeOptical Coherence Tomography (OCT)
Interventions
DIAGNOSTIC_TEST

Coronary angiography with OCT

Intravascular imaging with Optical Coherence Tomography (OCT) in patients with chronic coronary syndrome who have been indicated for coronary angiographic will be used at the operator's discretion, for diagnostic purposes and/or to guide possible coronary artery disease treatment.

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Cardiologia, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06522074 - Evaluating the Role of IGF-1 and S-Klotho In Plaque Phenotype and Vulnerability: the VISION Study. | Biotech Hunter | Biotech Hunter